• BerendsAnnika M AAMADepartment of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Michiel N Kerstens, LendersJacques W MJWMDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.Department of Medicine III, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., and Henri J L M Timmers.
• Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
• J. Clin. Endocrinol. Metab. 2020 Sep 1; 105 (9).

AbstractPheochromocytomas and sympathetic paraganglioma (PPGL) are rare chromaffin cell tumors originating in the adrenal medulla and sympathetic paraganglia, respectively, which share the capacity to synthesize and release catecholamines. The incidence of PPGL has increased in recent years. Surgical resection is the only curative treatment for PPGL. Management of patients with PPGL is complex and should be done by a specialized multidisciplinary team in centers with broad expertise. Surgical resection of a PPGL is a high-risk procedure for which optimal pretreatment with antihypertensive drugs is required in combination with state-of-the-art surgical procedures and anesthesiological techniques. In this article we discuss the underlying evidence and the pros and cons of presurgical medical preparation. Finally, the areas of uncertainty and controversies in this field are addressed.© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

35 keywords...

hide…